The risk for autoimmune disease among teenage girls does not increase after they receive the quadrivalent HPV vaccine, according to findings published in the Canadian Medical Association Journal.
“Despite demonstrated effectiveness in real-world settings, concerns continue to persist regarding the safety of the [quadrivalent human papillomavirus (HPV4)] vaccine,” Jeffrey Kwong, MD, MSc, a coauthor of the study and senior scientist at the Institute for Clinical Evaluative Sciences and Public Health Ontario, Toronto, said in a press release. “In light of these concerns, we
Uncategorized